The session focused on “Biomanufacturing of Enzymes,” a critical domain under the BioE3 Policy.
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
Support for biologics manufacturability and Industry 4.0 initiatives
Support for bioprocess, cell and gene therapy, and industry 4.0 initiatives
Bangladesh, Indonesia, Pakistan, Serbia and Vietnam to receive mRNA technology from the technology transfer hub
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
Enhanced alignment to better serve customers across the entire drug development lifecycle under the Fujifilm Life Sciences brand umbrella with the tagline Partners for Life
Awards highlight Avantor's commitment to the Biopharma industry
Biotech potential of Himalayan territories including Jammu & Kashmir, particularly their agri-biotech potential remains still under-explored
Subscribe To Our Newsletter & Stay Updated